Drug and alcohol review最新文献

{"title":"Assessing the Concurrent Validity of the Australian Treatment Outcomes Profile in a Methamphetamine Dependent Treatment-Seeking Population","authors":"Brendan Clifford,&nbsp;Rachel M. Deacon,&nbsp;Kristie Mammen,&nbsp;Krista J. Siefried,&nbsp;Nadine Ezard,&nbsp;Nicholas Lintzeris","doi":"10.1111/dar.70224","DOIUrl":"10.1111/dar.70224","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Introduction</h3>\u0000 \u0000 <p>The Australian Treatment Outcomes Profile (ATOP) is a brief clinical tool assessing substance use, health and well-being used in Australian alcohol and other drug treatment services. It is validated for use with clients using alcohol, opioids and cannabis, but not yet for clients who primarily use methamphetamine.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>An embedded validation study was undertaken in treatment-seeking adults enrolled in a randomised double-blind placebo-controlled trial of lisdexamfetamine for methamphetamine dependence with sites in New South Wales, South Australia and Victoria. Participant demographics were collected during study screening. The ATOP and comparators (Time Line Follow Back, Opiate Treatment Index, Depression Anxiety Stress Scale, WHOQOL-BREF and Personal Wellbeing Index) were collected at baseline. Continuous ATOP items were analysed using Pearson's correlation coefficient, and dichotomous items were analysed using Fleiss's <i>κ</i>. Agreement was rated as strong where measures were ≥ 0.50, moderate where agreement was 0.30–0.49, and weak where &lt; 0.30.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>One hundred and eighteen study participants (2018–2020) had data for concurrent validity analysis. Strong validity was demonstrated for physical health, psychological health, quality of life, injecting drug use and crime items, and for days of use for amphetamines, alcohol, cannabis and cocaine. There was weak validity for days of use for benzodiazepines. Heroin use days and other opioid use days were endorsed by fewer than five participants and were therefore unable to be assessed.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Discussion and Conclusions</h3>\u0000 \u0000 <p>The ATOP is valid for use in a treatment-seeking methamphetamine-dependent population, expanding the range of tools for assessment and standardised outcome monitoring across different settings and services.</p>\u0000 </section>\u0000 </div>","PeriodicalId":11318,"journal":{"name":"Drug and alcohol review","volume":"45 6","pages":""},"PeriodicalIF":2.9,"publicationDate":"2026-08-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/dar.70224","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148705870","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Simultaneous versus Sequential Cessation of Tobacco and Cannabis: Preferences of Young Adults Who Co-Use in France","authors":"Tangui Barré,&nbsp;Géraldine Cazorla,&nbsp;Vincent Leroy,&nbsp;Gwenaëlle Maradan,&nbsp;Clotilde Couderc,&nbsp;Julia de Ternay,&nbsp;Carlotta Magnani,&nbsp;Patrizia Carrieri","doi":"10.1111/dar.70221","DOIUrl":"10.1111/dar.70221","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Introduction</h3>\u0000 \u0000 <p>Co-use of tobacco and cannabis is common among young adults and is associated with higher dependence and quitting difficulties. Little is known about the preference for simultaneous or sequential dual cessation in this population. We aimed to explore preferences for the timing of dual cessation and the methods most likely to be used by young adults who co-use.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>Data came from an online nationwide cross-sectional survey of people co-using tobacco and cannabis in France. Preferences for the timing of dual cessation were modelled using binary logistic and multinomial regressions among participants aged 18–30 years. We also described cessation methods (for tobacco and cannabis separately) previously tried and those considered likely to be used in future quit attempts.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Among 357 young adults (54.9% men; median age 24), those using tobacco daily and cannabis ≥ 20 days/month had a 56% lower likelihood of preferring simultaneous over sequential cessation (adjusted odds ratio 0.44 [0.21–0.90], <i>p</i> = 0.024) compared with participants with the least frequent co-use. Participants who perceived their tobacco use as more harmful than their cannabis use were more likely to prefer quitting tobacco first. Across past and future attempts, the most cited methods for both substances were sport, cannabidiol, electronic cigarettes and nicotine replacement therapy.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Discussion and Conclusions</h3>\u0000 \u0000 <p>Simultaneous cessation appeared more acceptable to young adults with lower-risk co-use patterns. Overall, the likelihood of using recommended cessation methods was low. Further research is needed to develop effective and acceptable sequential cessation strategies for young adults who co-use these substances.</p>\u0000 </section>\u0000 </div>","PeriodicalId":11318,"journal":{"name":"Drug and alcohol review","volume":"45 6","pages":""},"PeriodicalIF":2.9,"publicationDate":"2026-08-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13453397/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148700977","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Characterising the Beyond 50 Cohort: Preliminary Exploration of Physical and Psychosocial Health Factors and Substance Use Among a Cohort of Community Dwelling Adults Aged 50–70 Years","authors":"Rose Laing,&nbsp;Tina Lam,&nbsp;Bosco Rowland,&nbsp;Paul Dietze,&nbsp;Aislinn Lalor,&nbsp;Keith D. Hill,&nbsp;Laura Alfrey,&nbsp;Nadine E. Andrew,&nbsp;Shalini Arunogiri,&nbsp;Stephen Bright,&nbsp;Louisa Picco,&nbsp;Suzanne Nielsen","doi":"10.1111/dar.70228","DOIUrl":"10.1111/dar.70228","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Introduction</h3>\u0000 \u0000 <p>Older adults exhibit unique risks associated with poor mental health and substance use. The Beyond 50 study is a longitudinal cohort investigating the determinants of healthy ageing, including relationships between physical and psychosocial health and substance use. We aim to characterise the Beyond 50 cohort and explore patterns of physical and psychosocial health and substance use.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>Baseline data collection was completed between September 2023 and August 2024. Annual follow-up data collection commenced in September 2024. Descriptive statistics will be used to characterise the cohort at the time of baseline survey completion.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Of the 1059 participants, the mean age was 61 years (standard deviation 0.2 years) and 46.8% were female. Just over half (52.4%, <i>n</i> = 555) received a positive screen for potentially hazardous alcohol consumption (past 12-month use), 8.7% (<i>n</i> = 92) reported recent tobacco use, 3.7% (<i>n</i> = 39) reported recent cannabis use and 5.5% (<i>n</i> = 58) reported other nonmedical substance use. Twelve percent (<i>n</i> = 134) screened positive for the symptoms of moderate to severe anxiety, 16.4% (<i>n</i> = 174) screened positive for the symptoms of moderate to severe depression, 15.7% (<i>n</i> = 166) were moderately to severely lonely and 22.6% (<i>n</i> = 239) reported being dissatisfied with their social relationships.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Discussion and Conclusion</h3>\u0000 \u0000 <p>The Beyond 50 cohort displays high rates of alcohol use, with levels of social isolation, loneliness, anxiety and depression comparable to the broader Victoria population. This lends to the cohort's ability to provide further insight into factors that affect healthy ageing and will allow for detailed analysis into the impacts of various physical and psychosocial factors on overall health and wellbeing.</p>\u0000 </section>\u0000 </div>","PeriodicalId":11318,"journal":{"name":"Drug and alcohol review","volume":"45 6","pages":""},"PeriodicalIF":2.9,"publicationDate":"2026-08-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13453339/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148700936","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Exploring the Dose–Response Relationship Between Alcohol Consumption and Harm to Others in Australia","authors":"Koen Smit,&nbsp;Heng Jiang,&nbsp;Katherine J. Karriker-Jaffe,&nbsp;Anne-Marie Laslett","doi":"10.1111/dar.70226","DOIUrl":"10.1111/dar.70226","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Introduction</h3>\u0000 \u0000 <p>Alcohol consumption often leads to harm to individuals other than the drinker. Yet, few studies have quantified an exposure-response gradient using “nominated” drinkers' alcohol volume and their heavy episodic drinking (HED) frequency to predict harm-type burden and overall severity among people harmed by someone else's alcohol use. We examined these dose–response relationships across sociodemographic groups.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>Data were drawn from the cross-sectional Australian 2021 Alcohol's Harm to Others (AHTO) Survey. A total of 2574 adults (18+ years) participated, of whom 554 reported harm from another person's drinking in the past 12 months. Respondents identified the person who harmed them the most (the “nominated drinker”) and reported on the person's weekly alcohol volume and frequency of HED. Harms experienced included an overall harm score (0–10 scale) and a count of 14 specific harms.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>There was a significant positive dose–response relationship between the nominated drinker's alcohol consumption (both weekly volume and frequency of HED) and the degree of harm experienced by respondents. Although subgroup analyses suggested stronger effects among women, younger respondents, and when the drinker was a (former) partner, these differences were not statistically significant.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Discussion and Conclusions</h3>\u0000 \u0000 <p>Greater alcohol consumption and more frequent HED are associated with more severe harms to others, regardless of respondents' sociodemographic background. A clear dose–response relationship exists between alcohol consumption by a known drinker and harm to others. The dose–response gradient was stronger at higher exposure levels, suggesting that reducing very frequent heavy drinking may yield disproportionately larger reductions in AHTO burden.</p>\u0000 </section>\u0000 </div>","PeriodicalId":11318,"journal":{"name":"Drug and alcohol review","volume":"45 6","pages":""},"PeriodicalIF":2.9,"publicationDate":"2026-08-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13449624/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148683871","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Practice Challenges and Research Directions in Rural Drug and Alcohol Treatment: A Focus Group Study of Clinician Perspectives","authors":"Julaine Allan,&nbsp;Catherine Keniry,&nbsp;Meredith Eagle,&nbsp;Stan Theodorou","doi":"10.1111/dar.70232","DOIUrl":"10.1111/dar.70232","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Introduction</h3>\u0000 \u0000 <p>Substance use and related mental illness contribute substantially to Australia's disease burden, with disproportionately high impacts in rural areas where access to specialist care is limited. Understanding local service challenges is critical to improving care delivery and guiding contextually relevant research. The aims of this study were to identify: (i) practice challenges; (ii) practice improvement priorities; and (iii) research priorities among rural drug and alcohol clinicians in Western NSW Local Health District.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>A pragmatic qualitative study was conducted using structured focus groups informed by a modified Delphi approach. Three focus groups (two in-person, one online) were held with 16 clinicians from diverse drug and alcohol programs. Discussions were guided by regional treatment data and a clinician workforce survey. Data were audio-recorded, transcribed and analysed using deductive qualitative content analysis, with findings validated through participant member checking.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Four themes were identified. Service gaps and access barriers included fragmented mental health and drug and alcohol systems, transport limitations, stigma and cultural safety concerns for Aboriginal clients. Workforce and training needs reflected staff shortages, limited preparation for integrated care and insufficient support for vicarious trauma. Technology and innovation were viewed as promising, particularly telehealth, but were constrained by cost, policy and implementation uncertainty. Research priorities focused on developing and evaluating integrated care models, virtual and brief interventions, culturally responsive services, workforce wellbeing and social determinants including housing, transport and stigma.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Discussion and Conclusions</h3>\u0000 \u0000 <p>Persistent structural and workforce challenges shape rural service delivery. Addressing these requires pragmatic, locally grounded research and stronger partnerships between health services and universities to support implementation of context-specific solutions.</p>\u0000 </section>\u0000 </div>","PeriodicalId":11318,"journal":{"name":"Drug and alcohol review","volume":"45 6","pages":""},"PeriodicalIF":2.9,"publicationDate":"2026-08-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13451612/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148688662","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Composition and Labelling Accuracy of Products Sold as Retatrutide in Australia","authors":"Timothy Piatkowski,&nbsp;Alison Craven,&nbsp;Samuel Cornell,&nbsp;Jason Ferris","doi":"10.1111/dar.70231","DOIUrl":"10.1111/dar.70231","url":null,"abstract":"","PeriodicalId":11318,"journal":{"name":"Drug and alcohol review","volume":"45 6","pages":""},"PeriodicalIF":2.9,"publicationDate":"2026-08-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148677523","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Unusually Large Effect Sizes and Confidence Intervals: Too Big to be True?","authors":"Murthy N. Mittinty,&nbsp;Natalie Walker","doi":"10.1111/dar.70223","DOIUrl":"10.1111/dar.70223","url":null,"abstract":"","PeriodicalId":11318,"journal":{"name":"Drug and alcohol review","volume":"45 6","pages":""},"PeriodicalIF":2.9,"publicationDate":"2026-08-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148677586","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Beyond Better Data: A Call for Improved Responses to Alcohol and Other Drug Harms Among Culturally and Linguistically Diverse Communities in Australia","authors":"Winifred Asare-Doku,&nbsp;Catherine Foley,&nbsp;Robert Stirling,&nbsp;Teguh Syahbahar,&nbsp;Nirekha De Silva,&nbsp;David Kelly,&nbsp;Amy Peacock,&nbsp;Stella Settumba","doi":"10.1111/dar.70218","DOIUrl":"10.1111/dar.70218","url":null,"abstract":"<p>People from culturally and linguistically diverse (CALD) backgrounds are recognised as a priority population in Australia's National Drug Strategy due to their potential vulnerability to alcohol and other drug (AOD)-related harms. National data consistently report low levels of AOD use and treatment utilisation among CALD populations. This discrepancy is likely due in part to limitations in data capture, such as the narrow definitions of CALD variables used, as well as issues of underreporting. Current reporting does not always align with Australian Bureau of Statistics standards and may also fail to capture the complexity and diversity of CALD communities. While improving data collection is essential, data alone will not address barriers to treatment engagement or ensure tailored, culturally responsive care. This editorial argues for two complementary actions: strengthening the collection of CALD data in national datasets and developing a tailored and adaptable AOD treatment framework, co-designed with CALD communities.</p>","PeriodicalId":11318,"journal":{"name":"Drug and alcohol review","volume":"45 6","pages":""},"PeriodicalIF":2.9,"publicationDate":"2026-08-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13437198/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148677526","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Preferences for Smartphone Versus In-Person Delivery of Contingency Management: A Web-Based Survey of Australians Who Use Methamphetamine","authors":"Rebecca McKetin,&nbsp;Annelies L. Robijn,&nbsp;Simon Clay,&nbsp;Shalini Arunogiri,&nbsp;Samantha Colledge-Frisby,&nbsp;Alison D. Marshall,&nbsp;Louisa Degenhardt,&nbsp;Rachel Sutherland,&nbsp;Long Nguyen,&nbsp;Michael Christmass,&nbsp;Zachary Wilkinson,&nbsp;Dean Membrey,&nbsp;Paul McCartney,&nbsp;Jack Nagle,&nbsp;Tayla Degan,&nbsp;Michael Farrell,&nbsp;Meredith Ginley","doi":"10.1111/dar.70219","DOIUrl":"10.1111/dar.70219","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Introduction</h3>\u0000 \u0000 <p>Smartphone delivery of contingency management (CM) could overcome barriers to dissemination of this effective treatment for methamphetamine use. We quantified help-seeking intentions for CM and preferences for smartphone versus in-person delivery of CM amongst people who used methamphetamine.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>An open web-based cross-sectional survey of 220 Australian residents who had used methamphetamine weekly or more often in the past year was conducted. Help-seeking intentions for CM were compared to other available treatment options using the General Help Seeking Questionnaire. Preferences for three CM models: in-person voucher-based CM, in-person prize-based CM and a smartphone-delivered model of CM, were sought, along with preferences for other aspects of CM delivery.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Help-seeking intentions were similar for CM and other treatment options (82% vs. 76%–81% likely to seek help). Smartphone delivery of CM was preferred by 43% of participants (cf. 27% for in-person voucher CM and 30% for in-person prize draw CM). Overall, other preferences were for a fixed (predictable) reinforcement schedule (78%), cash (53%) or gift card (40%) rewards rather than merchandise (7%), and adjunctive support (78%) – mostly counselling (50%) and withdrawal management (43%). Participants wanted a median minimum payment of $69 (interquartile range $58–$77) to start CM, and a minimal median potential earnings of $4000 (interquartile range $3600–$4500) over a 12-week program.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Discussion and Conclusions</h3>\u0000 \u0000 <p>We found strong potential demand for smartphone-delivered CM, although adjunctive counselling and withdrawal management would be needed and incentives may need to be larger than those used in conventional CM models.</p>\u0000 </section>\u0000 </div>","PeriodicalId":11318,"journal":{"name":"Drug and alcohol review","volume":"45 6","pages":""},"PeriodicalIF":2.9,"publicationDate":"2026-08-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13437133/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148677561","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Long-Acting Injectable Buprenorphine in Prison: Insights From a Short-Answer Survey of People in the Criminal Justice System Commencing Long-Acting Injectable Buprenorphine During a Non-Randomised Clinical Trial","authors":"Amelia Woods,&nbsp;Catherine Foley,&nbsp;Adrian Dunlop,&nbsp;Bethany White,&nbsp;Elizabeth McEntyre,&nbsp;Nicholas Lintzeris,&nbsp;Paul S. Haber,&nbsp;Jillian Roberts,&nbsp;Michael Doyle","doi":"10.1111/dar.70214","DOIUrl":"10.1111/dar.70214","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Introduction</h3>\u0000 \u0000 <p>Long-acting injectable buprenorphine (LAIB) is increasingly used in the Criminal Justice System (CJS) for treating people with opioid use disorder; however, little is known about these patients' experiences. We aimed to understand the perspectives of participants commenced on LAIB in prison as a part of the Understanding NSW Long-Active Opioids in Custody-Treatment (UNLOC-T) study.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>Results of an open-ended survey administered by UNLOC-T researchers underwent analysis. Participants were adults, recruited November 2018–July 2019, with moderate–severe opioid use disorder and ≥ 6 months remaining on their sentence. We conducted a thematic analysis using a pragmatic, descriptive coding approach.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Sixty-seven participants were included, of which 82% were male. Five primary themes were identified that described participants' experiences and highlighted issues that can directly inform service delivery: medication effectiveness, social and relational considerations, dosing frequency, financial aspects, and health and wellbeing. There was considerable variation in participant perspectives within themes.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Discussion and Conclusions</h3>\u0000 \u0000 <p>Perspectives on LAIB are diverse, suggesting a need to individualise treatment and ensure person-centered care. While LAIB offers benefits to warrant including it as a treatment option, challenges remain. Future research into LAIB in the CJS would allow for triangulation, as well as further exploration of ongoing acceptability in the post-release period. Our findings could help to improve the way LAIB is offered as a treatment option or delivered to people in the CJS. There are also lessons for prescribers in counselling and tailoring treatment, and broader policy considerations around access to treatment formulations and patient autonomy.</p>\u0000 </section>\u0000 </div>","PeriodicalId":11318,"journal":{"name":"Drug and alcohol review","volume":"45 6","pages":""},"PeriodicalIF":2.9,"publicationDate":"2026-08-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13433967/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148668493","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}